A pioneer of intensity-modulated radiation therapy (IMRT), Nomos of Sewickley, PA, has launched a remote treatment planning service that promises to provide treatment facilities more rapid access to this type of radiation therapy. The product, Nomos Rx,
A pioneer of intensity-modulated radiation therapy (IMRT), Nomos of Sewickley, PA, has launched a remote treatment planning service that promises to provide treatment facilities more rapid access to this type of radiation therapy. The product, Nomos Rx, is aimed at treatment facilities that might not be able to implement a quality IMRT program due to the cost of resources and equipment required. IMRT allows the delivery of increased radiation doses to tumor while limiting the impact on surrounding healthy tissue.
Additionally, the privately held company has struck an agreement to partner with MCP International, a remarketer of radiation therapy equipment, to provide an IMRT package that includes a linear accelerator, multileaf collimator, CT scanner, and inverse treatment planning software. Nomos Peacock System will be coupled with MCP's refurbished digital linear accelerator and spiral CT scanning equipment to provide a turnkey integrated equipment package available for less than the cost of a new IMRT-capable linear accelerator.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.